Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Praxis
|
October 26, 2022
[CME: Diagnostic Approach and Management of Thrombotic Microangiopathy]
Tabea Sutter, Thomas Fehr, Reto Venzin
Hematology (Amsterdam, Netherlands)
|
December 11, 2023
Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis
Tabea Sutter, Marcus Schittenhelm, Thomas Volken, et al.
Clinical Advances in Hematology & Oncology : H&O
|
December 19, 2019
HIV protease inhibitors for the treatment of multiple myeloma
Max Mendez-Lopez, Tabea Sutter, Christoph Driessen, et al.
BMJ Case Reports
|
July 3, 2023
Stillbirth and fulminant postpartum haemolysis: COVID-19 or leptospirosis or both?
Tabea Sutter, Thomas Fehr, Carolin Blume, et al.
Obstetric Medicine
|
November 13, 2025
Management of sickle cell disease in pregnancy
Tabea Sutter, Nadine Shehata, Kristine Matusiak, et al.
British Journal of Haematology
|
January 3, 2024
Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab
Roman R Schimmer, Tabea Sutter, Adrian Bachofner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 15, 2016
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern
Björn Zörner, Linard Filli, Katja Reuter, et al.
Neurology
|
February 3, 2017
Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis
Linard Filli, Björn Zörner, Sandra Kapitza, et al.
Scientific Reports
|
March 23, 2018
Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time
Linard Filli, Tabea Sutter, Christopher S Easthope, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Praxis
|
October 26, 2022
[CME: Diagnostic Approach and Management of Thrombotic Microangiopathy]
Tabea Sutter, Thomas Fehr, Reto Venzin
Hematology (Amsterdam, Netherlands)
|
December 11, 2023
Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis
Tabea Sutter, Marcus Schittenhelm, Thomas Volken, et al.
Clinical Advances in Hematology & Oncology : H&O
|
December 19, 2019
HIV protease inhibitors for the treatment of multiple myeloma
Max Mendez-Lopez, Tabea Sutter, Christoph Driessen, et al.
BMJ Case Reports
|
July 3, 2023
Stillbirth and fulminant postpartum haemolysis: COVID-19 or leptospirosis or both?
Tabea Sutter, Thomas Fehr, Carolin Blume, et al.
Obstetric Medicine
|
November 13, 2025
Management of sickle cell disease in pregnancy
Tabea Sutter, Nadine Shehata, Kristine Matusiak, et al.
British Journal of Haematology
|
January 3, 2024
Successful management of refractory immune-mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti-VWF nanobody caplacizumab
Roman R Schimmer, Tabea Sutter, Adrian Bachofner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 15, 2016
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern
Björn Zörner, Linard Filli, Katja Reuter, et al.
Neurology
|
February 3, 2017
Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis
Linard Filli, Björn Zörner, Sandra Kapitza, et al.
Scientific Reports
|
March 23, 2018
Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time
Linard Filli, Tabea Sutter, Christopher S Easthope, et al.
Page
of 1